Thalamic nuclei degeneration in multiple sclerosis.

Abstract Objectives To define both the severity and extent of structural alteration in certain thalamic nuclei by means of MR morphometry and to compare these findings with clinical performance in different phenotypes of multiple sclerosis (MS). Methods We comparatively measured the thalamus nuclei volumes of patients with remitting-relapsing (RRMS) and secondary-progressive (SPMS) phenotypes of multiple sclerosis and healthy control subjects (HC). The evaluation of neurological performance was based on the results of Expanded Disability Status Scale and Multiple Sclerosis Severity Scale. Cognitive and mental state was rated according to the results of Mini-Mental State Examination, Frontal Assessment Battery, Montreal Cognitive Assessment and Symbol Digit Modalities Test. Freesurfer 6.0 was used for thalamic nuclei volumes calculation. Results The median volume decline in thalamic pulvinar nuclei in RRMS group on the left side (anterior nucleus − 186,6 mm3, posterior nucleus – 149,4 mm3, medial nucleus 852,4 mm3) compared to HC (anterior nucleus – 229,2 mm3, posterior nucleus – 187,5 mm3, medical nucleus – 1081,3 mm3). Same group, right side – anterior nucleus – 219,5 mm3, posterior nucleus 187,1 mm3, medial nucleus – 989,6 mm3; HC group – anterior nucleus 261,1 mm3, posterior nucleus 240,5 mm3, medial nucleus – 1196,7 mm3 (p  Conclusion These findings indicate the credible correlation between clinical progression of neurological and cognitive impairment in MS patients with asymmetry left-sided thalamic nuclei atrophy and may be considered a potential predicting tool of MS progression.